Derek N. Adams's most recent trade in Kalaris Therapeutics Inc. was a trade of 35,000 Common Stock done . Disclosure was reported to the exchange on June 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Kalaris Therapeutics Inc. | Derek N. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 70,000 | - | 0 | Common Stock | |
Kalaris Therapeutics Inc. | Derek N. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 35,000 | - | 0 | Common Stock | |
Kalaris Therapeutics Inc. | Derek N. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) |